Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study

Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to improved blood sugar control in ...
Zacks Investment Research on MSN

DXCM receives FDA clearance for Stelo OTC CGM system for children

DexCom DXCM received FDA clearance for its Stelo Glucose Biosensor System for use in children aged two years and older who do ...
CNET

The FDA Just Cleared the First OTC Continuous Glucose Monitor for Children

Stelo can now be marketed for children 2 years of age and older who do not use insulin.

Dexcom scores pediatric expansion for OTC Stelo glucose monitor

The U.S. Food and Drug Administration (FDA) on Friday cleared Dexcom Inc.‘s DXCM Stelo Glucose Biosensor System for ...

In a first, Dexcom’s OTC glucose sensor is cleared for kids

Dexcom has received Food and Drug Administration clearance for the first over-the-counter glucose sensor for children. The ...
Medical Device and Diagnostic Industry (MD+DI)

Suppliers Discuss Design Challenges for Pediatric Wearables

Dexcom is taking over-the-counter continuous glucose monitors to the pediatric population. The San Diego, CA-based company ...

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin

DexCom, Inc. (NASDAQ:DXCM) announced today results from the CONNECT randomized controlled trial, demonstrating the use of ...

DexCom Expands Beyond CGMs With CONNECT Results AI Apps And Nutrisense Deal

DexCom (NasdaqGS:DXCM) reported new clinical data from its CONNECT trial on the Dexcom G7 continuous glucose monitoring system in adults with Type 2 diabetes not using insulin. The company introduced ...

Apple Watch Glucose Monitoring Apps: What Works Now and What Needs Your iPhone

Compare Apple Watch CGM apps for blood sugar readings, including Dexcom G7, FreeStyle Libre, and Eversense watch support.
MobiHealthNews

FDA approves Dexcom G5 for use without a fingerstick glucometer

The FDA has officially cleared the Dexcom G5 continuous glucose monitor to inform treatment decisions -- without the use of a fingerstick glucometer, other than for calibration. The G5 has been ...
Business Wire

Dexcom G6 Continuous Glucose Monitoring (CGM) System Receives CE Mark for Use During Pregnancy in the EU

MADRID--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM), announced today the Dexcom G6 CGM System has received the CE Mark for use during pregnancy in ...